Corpus Intelligence IC Memo — ST. JOSEPH MEDICAL CENTER 2026-04-26 03:43 UTC
IC Memo — ST. JOSEPH MEDICAL CENTER
Investment Committee Memorandum | PA | 132 beds | Grade C | EBITDA uplift $24.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ST. JOSEPH MEDICAL CENTER

CCN 390096 | BERKS, PA | 132 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ST. JOSEPH MEDICAL CENTER is a 132-bed suburban community hospital in BERKS, PA with $334.8M in net patient revenue and a 13.2% operating margin. The hospital serves a payer mix of 26.1% Medicare, 1.3% Medicaid, and 72.6% commercial.

Thesis: Turnaround. Our ML models identify $24.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 13.2% to 20.6% (+736bps).

Net Revenue HCRIS$334.8M
Current EBITDA COMPUTED$44.3M
Operating Margin COMPUTED13.2%
Occupancy HCRIS66.9%
Revenue / Bed COMPUTED$2.5M
Net-to-Gross HCRIS24.6%
Distress Probability ML41.1%

2. Market Context & Competitive Position

225
PA Hospitals
-4.4%
State Median Margin
105
Comparable Hospitals

PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of 13.2% places it above the state median. Among 105 size-comparable peers (66-264 beds), the median margin is -7.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (66-264), prioritizing same-state peers. 105 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ST. JOSEPH MEDICAL CENTER (Target)PA132$334.8M13.2%
WESTERN PENNSYLVANIA HOSPITALPA255$776.4M11.1%
ROBERT PACKER HOSPITALPA252$471.8M-2.1%
WILLIAMSPORT HOSPITAL & MEDICAPA227$459.8M-8.4%
MOUNT NITTANY MEDICAL CENTERPA248$441.7M12.6%
MEMORIAL MEDICAL CENTERPA241$435.1M-21.2%
THE CHAMBERSBURG HOSPITALPA234$435.1M5.2%
ST LUKE HOSPITAL ANDERSON CAMPPA193$433.0M20.6%
DUBOIS REGIONAL MEDICAL CENTERPA247$429.3M-15.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $24.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$7.0M+210bp18mo
Cost to Collect4.5%2.5%$6.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$6.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.1M+122bp9mo
Clean Claim Rate88.0%96.0%$214K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$7.0M
Cost to Collect
$6.7M
Denial Rate Reduction
$6.6M
A/R Days Reduction
$4.1M
Clean Claim Rate
$214K
Total EBITDA Uplift$24.6M
Current EBITDA$44.3M
+ RCM Uplift+$24.6M
Pro Forma EBITDA$68.9M
Current Margin13.2%
Pro Forma Margin20.6%
WC Released (1x)$12.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$68.1M$538.5M7.91x51.2%
Base (11x exit)10.0x11.0x$68.1M$614.5M9.02x55.2%
Bull Case9.0x11.0x$61.3M$717.9M11.71x63.6%
Bull (12x exit)9.0x12.0x$61.3M$801.3M13.07x67.2%
Bear Case11.0x10.0x$74.9M$393.1M5.25x39.3%
Bear (11x exit)11.0x11.0x$74.9M$456.8M6.10x43.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 105 hospitals with 66-264 beds
  • Same-state prioritization (n=106)
  • Comp margins: P25=-18.6% / P50=-7.5% / P75=5.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.